Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 3,533 | 4,970 | 6,357 | 4,410 | 5,195 |
| Cost of Goods | 1,090 | 840 | 450 | 780 | 300 |
| Gross Profit | 2,430 | 1,620 | 5,900 | 3,620 | 4,890 |
| Operating Expenses | 4,930 | 5,920 | 4,110 | 4,380 | 4,180 |
| Operating Income | -2,397 | -950 | 2,247 | 30 | 1,015 |
| Interest Expense | 0 | 40 | 0 | 0 | 0 |
| Other Income | 727 | 110 | 123 | -90 | 5 |
| Pre-tax Income | -1,670 | -880 | 2,370 | -60 | 1,020 |
| Income Tax | 0 | -550 | 0 | N/A | N/A |
| Net Income Continuous | -1,673 | -316 | 2,373 | -68 | 1,027 |
| Net Income | $-1,673 | $-316 | $2,373 | $-68 | $1,027 |
| EPS Basic Total Ops | -0.10 | -0.02 | 0.15 | 0.00 | 0.07 |
| EPS Basic Continuous Ops | -0.10 | -0.02 | 0.15 | 0.00 | 0.06 |
| EPS Diluted Total Ops | -0.10 | -0.02 | 0.14 | 0.00 | 0.07 |
| EPS Diluted Continuous Ops | -0.10 | -0.02 | 0.15 | 0.00 | 0.06 |
| EBITDA(a) | $-1,947 | $-450 | $2,247 | $30 | $1,015 |